These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23530148)

  • 1. CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cells.
    Dessarthe B; Thedrez A; Latouche JB; Cabillic F; Drouet A; Daniel P; de La Pintière CT; Catros V; Toutirais O
    J Immunol; 2013 May; 190(9):4868-76. PubMed ID: 23530148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM.
    Boles KS; Barchet W; Diacovo T; Cella M; Colonna M
    Blood; 2005 Aug; 106(3):779-86. PubMed ID: 15811952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterotypic interaction of CRTAM with Necl2 induces cell adhesion on activated NK cells and CD8+ T cells.
    Arase N; Takeuchi A; Unno M; Hirano S; Yokosuka T; Arase H; Saito T
    Int Immunol; 2005 Sep; 17(9):1227-37. PubMed ID: 16091383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape].
    Catros V; Dessarthe B; Thedrez A; Toutirais O
    Med Sci (Paris); 2014 May; 30(5):537-43. PubMed ID: 24939541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
    Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
    Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
    Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
    J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An abnormal phenotype of lung Vγ9Vδ2 T cells impairs their responsiveness in tuberculosis patients.
    El Daker S; Sacchi A; Montesano C; Altieri AM; Galluccio G; Colizzi V; Martini F; Martino A
    Cell Immunol; 2013 Apr; 282(2):106-12. PubMed ID: 23770719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.
    Todaro M; D'Asaro M; Caccamo N; Iovino F; Francipane MG; Meraviglia S; Orlando V; La Mendola C; Gulotta G; Salerno A; Dieli F; Stassi G
    J Immunol; 2009 Jun; 182(11):7287-96. PubMed ID: 19454726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition of cell adhesion and immune recognition: insights into the interaction between CRTAM and nectin-like 2.
    Zhang S; Lu G; Qi J; Li Y; Zhang Z; Zhang B; Fan Z; Yan J; Gao GF
    Structure; 2013 Aug; 21(8):1430-9. PubMed ID: 23871486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Vgamma9Vdelta2 T cells: from signals to functions.
    Nedellec S; Bonneville M; Scotet E
    Semin Immunol; 2010 Aug; 22(4):199-206. PubMed ID: 20447835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and transient activation of γδ T cells to IFN-γ production, NK cell-like killing, and antigen processing during acute virus infection.
    Toka FN; Kenney MA; Golde WT
    J Immunol; 2011 Apr; 186(8):4853-61. PubMed ID: 21383249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
    Liu Z; Guo B; Lopez RD
    J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
    Thedrez A; Harly C; Morice A; Salot S; Bonneville M; Scotet E
    J Immunol; 2009 Mar; 182(6):3423-31. PubMed ID: 19265120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger Vγ9Vδ2 T-cell antitumor cytotoxicity through ICAM-1 engagement.
    Benzaïd I; Mönkkönen H; Bonnelye E; Mönkkönen J; Clézardin P
    Clin Cancer Res; 2012 Nov; 18(22):6249-59. PubMed ID: 23032740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chicken CRTAM binds nectin-like 2 ligand and is upregulated on CD8+ αβ and γδ T lymphocytes with different kinetics.
    Zechmann M; Reese S; Göbel TW
    PLoS One; 2013; 8(12):e81942. PubMed ID: 24339981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.
    Lesport E; Baudhuin J; Sousa S; LeMaoult J; Zamborlini A; Rouas-Freiss N; Carosella ED; Favier B
    Cell Mol Life Sci; 2011 Oct; 68(20):3385-99. PubMed ID: 21337044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.
    Fuchs A; Colonna M
    Semin Cancer Biol; 2006 Oct; 16(5):359-66. PubMed ID: 16904340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human class-I restricted T cell associated molecule is highly expressed in the cerebellum and is a marker for activated NKT and CD8+ T lymphocytes.
    Patiño-Lopez G; Hevezi P; Lee J; Willhite D; Verge GM; Lechner SM; Ortiz-Navarrete V; Zlotnik A
    J Neuroimmunol; 2006 Feb; 171(1-2):145-55. PubMed ID: 16300832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class I-Restricted T Cell-Associated Molecule Is a Marker for IFN-γ-Producing iNKT Cells in Healthy Subjects and Patients with Type 1 Diabetes.
    Beristain-Covarrubias N; Canche-Pool EB; Ramirez-Velazquez C; Barragan-Galvez JC; Gomez-Diaz RA; Ortiz-Navarrete V
    J Interferon Cytokine Res; 2017 Jan; 37(1):39-49. PubMed ID: 27835062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of CRTAM gene promoter: AP-1 transcription factor control its expression in human T CD8 lymphocytes.
    Valle-Rios R; Patiño-Lopez G; Medina-Contreras O; Canche-Pool E; Recillas-Targa F; Lopez-Bayghen E; Zlotnik A; Ortiz-Navarrete V
    Mol Immunol; 2009 Oct; 46(16):3379-87. PubMed ID: 19695707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.